Fingerprint
Dive into the research topics where Efrat Broide is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Beyond eosinophils: A proteomic dissection of remodeling and inflammation in suspected eosinophilic esophagitis
Eindor-Abarbanel, A., Moss- Ophir, N., Agajany, N., Cohen, D. L., Richter, V., Shirin, H., Broide, E. & Shalem, T., Apr 2026, In: Journal of Pediatric Gastroenterology and Nutrition. 82, 4, p. 1078-1087 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Limited willingness to switch from intravenous to subcutaneous treatment in paediatric inflammatory bowel disease
Eindor-Abarbanel, A., Shalem, T., Badalov, O., Weiss, B., Cohen, D. L., Shalev, R., Yerushalmi, B., Yerushalmy-Feler, A., Topf Olivestone, C., Shirin, H., Broide, E. & Richter, V., 19 Jan 2026, In: BMJ Paediatrics Open. 10, 1, e004020.Research output: Contribution to journal › Article › peer-review
Open Access -
Paediatric-onset versus adult-onset eosinophilic oesophagitis: distinct atopic endotypes and clinical manifestations
Eindor- Abarbanel, A., Shalem, T., Broide, E., Cohen, D. L., Afianish, Y., Smadar-Shneyour, R., Abu-Juma, A., El-Saied, S. & Abu Freha, N., 2026, (Accepted/In press) In: Frontline Gastroenterology. flgastro-2025-103549.Research output: Contribution to journal › Article › peer-review
-
Upadacitinib Maintenance Therapy in Crohn’s Disease: Final Results From the Randomized Phase 3 U-ENDURE Study
Panaccione, R., Regueiro, M., Lee, S. D., Atreya, R., Pedersen, G., Broide, E., Rodriguez, C., van Bodegraven, A. A., Dubcenco, E., Lacerda, A. P., Feng, T., Geng, Z., Wang, T., van Haaren, S., Anyanwu, S. I. & Panés, J., Mar 2026, In: Clinical Gastroenterology and Hepatology. 24, 3, p. 772-783 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Ustekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg
UNITI Jr study Group, 1 Mar 2026, In: Journal of Crohn's and Colitis. 20, 3, jjag011.Research output: Contribution to journal › Article › peer-review
Open Access